Patent ID: 7879904

Claim:
A method for the treatment of cancer in a cancer patient, said cancer selected from the group consisting of Ovarian Carcinoma, Breast Cancer, Neuroblastoma and Squamous Cell Carcinoma, said method comprising administering a taxane compound to said cancer patient, wherein the taxane compound is made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: with a second compound of generalized formula R 8 R 9 C(OCH 3 ) 2 and an acid selected from the group consisting of camphor sulfonic acid (CSA), p-toluene sulfonic acid (PTSA), hydrochloric acid (HCl) and acetic acid (AcOH), wherein: R 1 and R 2 are each selected from H, an alkyl group, an olefinic group, an aromatic group, an O-alkyl group, an O-olefinic group, or an O-aromatic group; R 7 is an alkyl group, an olefinic group, or an aromatic group; P 1 is a hydroxyl protecting group; P 5 is H or an acid labile protecting group at the 7-O position; R 8 is: H, alkyl group, olefinic or aromatic group; and R 9 is: H, alkyl group, olefinic or aromatic or is: